Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and ...

Ending clinical trials with no warning can put patients at risk.

The drug manufacturer will no longer study and test danuglipron after a participant in a clinical trial was injured.

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

The Trump administration has reportedly disrupted over 100 clinical trials. Science News spoke to researchers about the impacts on four of them.

The company said it would stop studying the experimental drug, danuglipron, after a participant in one of its clinical trials experienced a possible drug-induced liver injury that ended once the ...

Parkinson’s is a progressive neurological condition driven by the loss of dopamine-producing neurons, which causes tremors, ...

Key Takeaways A pill to treat obesity caused liver injury in a clinical trialPfizer said it will stop developing the drug, called danuglipron, as a result Other alternatives to injectable obesity ...

Scientists warn that the consequences of their project suspensions could undo years of progress in strengthening healthcare ...

The drugmaker said Tuesday that it would stop studying danuglipron after a participant in one of its trials experienced a possible drug-induced liver injury that ended once the person stopped ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and most expensive level of clinical testing. The drugmaker said Tuesday ...